Safety Alert – ASV use in CHF Heart Failure Patients

Safety Alert – ASV use in CHF Heart Failure Patients

ResMed has recently issued a notice that warns patients about the use of adaptive servo ventilation (ASV). Preliminary data from the SERVE-HF study suggest that there is an increase in cardiovascular death in patients who have symptomatic heart failure with left ventricular ejection fraction  of less than 45-percent and are using ASV.

If you are using ASV or similar adaptive servo technology, talk to your doctor about your therapy plan.

http://www.resmed.com/content/dam/resmed/global/documents/serve-hf/Healthcare_Professionals_SERVE-HF_FAQs.pdf

 

http://www.resmed.com/content/dam/resmed/global/documents/serve-hf/Patient_SERVE-HF_FAQs.pdf

 

 

 

 

Share This: